CONTACT

Joint Chiefs of Staff General Mark A. Milley and US military personnel recognized for their leadership during the COVID-19 pandemic

December 20, 2022 23:05 ET| Source: Society for Brain Mapping & Therapeutics WASHINGTON, Dec. 20, 2022 (GLOBE NEWSWIRE) — Pentagon: In the past three years, American military personnel has tirelessly defended and supported the country while themselves in danger of contracting COVID-19 and, sadly, in many cases losing their lives in the line of duty. Military families have also suffered throughout this pandemic. However, they supported the selfless act of their loved ones in the uniform who devoted their lives to protecting Americans from the complication of this devastating viral disease and helping with vaccinations and care of millions of their compatriots. Today at the Pentagon, US Military personnel and the 20th Joint Chiefs of Staff General Mark A. Milley were recognized by two non-profit organizations, Brain Mapping Foundation (BMF) and Society for Brain Mapping and Therapeutics (SBMT). Over two decades, BMF and SBMT have been at the forefront of providing access to cutting-edge care for veterans and wounded soldiers through pioneering medical innovation and neurotechnology research. “It is our honor to show our gratitude to US military personnel and their families and thank General Milley for his leadership during this brutal pandemic for their valor and bravery, which has been leading to saving millions of our compatriots,” said Dr. Babak Kateb, Founding Chairman of the Board and CEO of SBMT, and President of BMF. BMF and SBMT have been at the forefront of fast-tracking therapeutics and diagnostics; some of these are immunotherapy, stem cell therapy, AI-based robotics prosthetic devices, nanomedicine, neurophotonics, brain mapping and multi-spectral imaging for neurological spine and neuropsychiatric disorders such as PTSD, brain cancer, and spinal trauma, as well as suicide prevention, opioid addiction treatments, neuro-regeneration and rehabilitation. “We are here at the Pentagon in person to assure General Milley, the US military personnel, and our fellow Americans that we are relentlessly supporting our troops and working 24/7 to ensure they have access to the game-changing and cutting-edge therapeutics,” said Dr. Vicky Yamamoto, 20th President, Executive Director of SBMT, and chairwoman of the SBMT-COVID19 global task force. SBMT and BMF created a task force and tackled COVID-19 pandemic through science, technology, innovation, and policy, and endorsed California Proposition 14. SBMT was instrumental in the passage of Proposition 14, which provides $5.5B in total to continue stem cell research, including $1.5B for the support of research and development of treatments for neurological disorders. The BMF also donated PPE and food to the local hospitals and published a landmark review position paper on COVID-19 in the Journal of Alzheimer’s Disease warning about post-COVID-19 brain disorders. Drs. Vicky Yamamoto (20th President of SBMT-chairwoman of award committee), Babak Kateb (founding chairman and CEO of SBMT and President of BMF), Ret. Colonel Michael Roy (10th President of SBMT/Co-chair of military medicine subcommittee), Deborah Zelinsky (SBMT board; chair of visual processing subcommittee), Keerthy Sunder (SBMT Board, Co-chair of psychiatry and psychedelic subcommittees), where part of the selection committee and the award was presented by Drs. Babak Kateb and Vicky Yamamoto to General Milley on December 19th, 2022, at the Pentagon. The 2023 (20th) Annual World Congress of SBMT (Brain, Spine and Mental Health) is scheduled to be held at the LA Convention Center on Feb 16th-19th, 2023, with near 900 invited speakers covering the latest neurotech innovations for neurological disorders including Bioskills/cadaver labs: www.WorldBrainMapping.org and the 20th Gathering for Cure Gala of Brain Mapping Foundation is scheduled to be held at Intercontinental Hotel on Friday, February 17th, 2023: https://www.worldbrainmapping.org/Annual-Awards-Gala/ About SBMT: The Society for Brain Mapping and Therapeutics (SBMT) is a non-profit society organized to encourage basic and clinical scientists interested in brain mapping, engineering, stem cell, nanotechnology, imaging, and medical devices to improve the diagnosis, treatment, and rehabilitation of patients afflicted with neurological disorders. This Society promotes public welfare and improves patient care by translating new technologies/therapies into lifesaving diagnostic and therapeutic procedures. SBMT is committed to excellence in education and scientific discovery. The Society achieves its mission through multidisciplinary collaborations with government agencies, patient advocacy groups, educational institutes, and industry, as well as a philanthropic organization: www.WorldBrainMapping.org About BMF: The Brain Mapping Foundation (BMF) is a non-profit 501c3 charitable organization established to facilitate multidisciplinary brain and spinal cord research and expedite the integration and translation of cutting-edge technologies into neuroscience. BMF is focused on translating state-of-the-art technologies from the space and defense industries into neuroscience to bring the most advanced medicine to wounded warriors as well as civilians: https://www.worldbrainmapping.org/Annual-Awards-Gala/ Media Contact: Dr. Joe F. BolanosSociety for Brain Mapping and TherapeuticsCOOCell: 661-607-5607Office: 310-500-6196Joe.Bolanos@brainmappingfoundation.org | www.worldbrainmapping.org Jessica Kopach-PaulsonP2R Inc.Email: jessi@p2rinc.comW: P2Rinc.com A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/42ad1a3a-f305-4ef8-943c-b331d5c06705

20th Annual “Gathering for Cure” Awards Gala of World Brain Mapping Foundation to recognize Pioneering Innovation, Technology, Policy, Humanitarian and Philanthropic work

Society for Brain Mapping & Therapeutics November 21, 2022·4 min read Tickets Now Available for the Star Studded Black-Tie Event hosted by Gabriella Wright and Dr. Babak Kateb with Special Guest Dr. Deepak Chopra LOS ANGELES, Nov. 21, 2022 (GLOBE NEWSWIRE) — Ticket registration is now open for the World Brain Mapping Foundation’s (WBMF) 20th Annual “Gathering for Cure” Awards Gala, taking place on Friday, February 17th, 2023, at the InterContinental Hotel in downtown Los Angeles. The Gala includes a cocktail/red carpet reception from 6-8pm, followed by a black-tie award banquet from 8-11pm and is part of the Annual World Congress of the Society for Brain Mapping and Therapeutics (SBMT), SBMT 2023 takes place from February 16th-19th at the Los Angeles Convention Center. For over 20 years, these two world-class scientific events have brought physicians, scientists, policymakers, funding agencies, and industry leaders together to advance applications in brain and spinal cord mapping and surgical and non-surgical image-guided therapies. Every year, the WBMF recognizes inspiring pioneers in the field, including scientific trailblazers, leading policymakers, technology developers, and individuals who helped to raise awareness about brain mapping, neurological disorders, mental health, and spinal disorders. “The Gala is the ‘Oscars of Neuroscience’,” says SBMT founder and WBMF President Dr. Babak Kateb. “This is a chance to celebrate pioneering work in our field while raising funding for our Brain technology and Innovation Park (BTIP), Neuroscience20, National Center for Nano-Bio-Electronics, Veterans and Wounded Soldiers and Ukraine Medical Humanitarian initiatives.” SBMT and WBMF work hand-to-hand to break boundaries, science, technology, medicine, art and healthcare policy by promoting innovative legislations and game-changing neurotech innovation and research that support rapid, safe, and cost-effective translation of new technologies into diagnostic and therapeutic applications. Every year, gala sponsors, partners (NIH, NASA, etc.), and donors gather during the convention for an evening of celebration to honor pioneering achievements. The event also builds crucial financial support for neurotech innovation and research that directly improves health outcomes for hundreds of millions of patients including veterans with neuro-psychiatric disorders such as: Alzheimer’s Disease (AD), ALS, brain cancer, chronic pain, depression, epilepsy neurotrauma (brain and spine), Multiple Sclerosis (MS), PTSD, Parkinson’s Disease (PD), suicide, and stroke (to name a few). Distinguished guests and past year’s awardees Dr. Deepak Chopra and Mr. Montel Williams are amongst celebrities who will be attending. Oscar and Golden Globe award recipient actress Goldie Hawn will attend and receive the 2023 Beacon of Courage and Dedication award. Previous recipients of this prestigious award include Professor Stephen Hawking (2015), and Harrison Ford (2021). Dr. Katrin Amunts is one of the recipients of the 2023 Pioneer in Medicine award. The Philips Healthcare Foundation will receive the 2023 Humanitarian award for its work in Ukraine. Past award recipients include Sanjay Gupta (Humanitarian 2021), and Anthony Fauci (Humanitarian 2021). Doctors Rajagopal Keerthy Sunder (SBMT board member), Brian Norling, and Chris Wheeler (SBMT board member) will receive the Golden Axon award; and SBMT fellows Drs. Natalya Fedorchenko, Kateryna Potapova, James Okereke, and Josthna Bodhanapati the Student Service and Leadership award. All Gala tickets (considered charitable donations) are tax deductible. Attendees, sponsors, and partners are invited to choose from special support packages such as: Join us for this exciting event aimed at raising funding and awareness to combat neuro-psychiatric disorders impacting veterans and the general public while supporting brain mapping research through generous individual philanthropic donations and corporate sponsorship. Live music, exciting auction items, and star studded entertainment will be part of this magnificent program. About the Brain Mapping Foundation: Brain Mapping Foundation (BMF) is a 501c3 charity focused on translating state-of-the-art technologies from the Space and defense industries into neuroscience to bring the most advanced medicine to wounded warriors and civilians. Founded in 2004 by Dr. Babak Kateb, the organization facilitates multidisciplinary neurology, neurosurgery, psychiatry, neuroscience, spine, mental health, neuroengineering and spinal cord research, along with expediting the integration and translation of cutting-edge technologies into the field of neuroscience. Learn more information on past award recipients, please visit: https://www.worldbrainmapping.org/Annual-Awards-Gala/ Media Contact:Tracy KeyserP2R Inc.Tracy@tracykeyser.com

9th Annual “N20” Neuroscience20 (Brain, Spine, and Mental Health) Summit to Shed Light On $16T+ Global Cost of Neuro-psychiatric Disorders

LOS ANGELES, Nov. 10, 2022 (GLOBE NEWSWIRE) — Launched nine years ago, Neuroscience20 (N20) educates global leaders and Group of Twenty (G20) leaders about the cost of neurological, spine, and mental disorders. Neurological disorders significantly impact the world’s economy due to their often chronic and life-threatening nature, creating a global disease burden. G20 member nations, representing the most significant economies globally, are invited to come together to formulate a plan to overcome this burden. The N20 – an initiative of the Society for Brain Mapping and Therapeutics (SBMT) – is at the forefront of this worldwide collaboration to comprehensively raise awareness about brain, spine, and mental disorders. “We studied the cost of neuro-psychiatric and spine disorders to the world economy, and it took us almost a year to compile the data. We discovered a total cost of over $16T annually to the world economy and $1.5T to the US economy. We published these findings in the Journal of Alzheimer’s Disease,” shares Dr. Vicky Yamamoto, co-author of the paper, 20th President of SBMT and Cancer scientist at USC-Keck School of Medicine and USC-Norris Comprehensive Cancer Center. This year’s N20 scientific and policy program includes speakers from across Indonesia and other G20 countries, as well as five keynotes: Drs. Ali Gufran Mukti, Robert Hariri, Vicky Yamamoto, Keerthy Sunder, and Jose Edgardo Valerio Pascua. The summit covers neurotech innovation in cellular therapeutics/immunotherapy; nanomedicine/nanoneurosurgery; AI machine learning; diagnostic, prognostic, and predictive modeling; neurotrauma; the Cancer Moonshot Initiative; suicide prevention; opioid addiction; epilepsy; radiosurgery; pain management; COVID-19 brain; rehabilitation; neurodegenerative disorders; neurovascular disorders; neuro-psychiatric disorders; and spine disorders. “We are truly honored to bring such a world-class scientific and global policy think tank to Indonesia. We urge Indonesian and Indian (2023 presidency of G20) sherpas to include the expansion of N20 – as well as addressing the cost of neuro-psychiatric disorders to the world economy – in the communique of the G20 as a whole,” says Dr. Asra Al-Fauzi, Professor of Neurosurgery, Chief of Neurovascular and Neuro-endovascular Therapy Center, Airlangga University and President of N20 Indonesia. US, European, Middle East and Balkans (ME+), Latin American (LA), and Asia Pacific (AP) Brain Initiatives will also be represented. In addition, the program will include a panel on the Global Medical Donor Summit for Ukraine as a part of the humanitarian mission of SBMT. “Through Neuroscience20, SBMT offers an open platform for international cooperation and partnership across G20 nations, which comprise the largest economies in the world. We are responding to our discovery of a lack of effective collaboration between nations and a lack of resources in developing countries. Current statistical analyses on the cost of neurological disorders to the world economy strongly suggest a great need for investment in neurotechnology and innovation or fast-tracking therapeutics and diagnostics to curb these costs. During the current COVID-19 pandemic, SBMT – through this summit and our publications – intends to showcase the importance of worldwide collaboration to reduce the population’s economic and health burden, specifically regarding neurological/brain, spine, and mental disorders,” explains Dr. Babak Kateb, Chairman of SBMT, President of the World Brain Mapping Foundation (WBMF), Director of the National Center for NanoBioElectronics, and Director of Brain Technology and Innovation (BTIP). This program is made possible by the generous contributions of: About SBMT: www.WorldBrainMapping.Org Contact information: Director of Public Relations at SBMT Jessca Kopach jessi@p2rinc.com Phone: 805-570-2599

Üsküdarlı Araştırmacılar Endonezya G20/N20 Zirvesinde…

Sinirbilim alanında küresel ölçekte seçkin bilim insanlarının yer aldığı Beyin Haritalama ve Tedavileri Derneği (Society for Brain Mapping and Therapeutics – SBMT) tarafından düzenlenen G20 – Neuroscience20 (BRAIN- SPINE- MENTAL- HEALTH) zirvesinin 9’uncusu Endonezya / Bali’de yapıldı. Üniversite olarak Türkiye’den tek Üsküdar Üniversitesinin katılım sağladığı Zirvede Prof. Dr. Nevzat Tarhan açılış konuşması gerçekleştirdi. Nöroteknoloji odaklı çalışmalarıyla uluslararası araştırmacılarca ilgi görmenin ve referans adres olmanın kendilerini mutlu ettiğini belirten Tarhan’a Endonezya’da bestseller listesine giren kitapları dolayısıyla “Bestseller” ödülü de takdim edildi. Türkiye’den iki bilim insanı… Konferansa Türkiye’den tek katılım sağlayan üniversite Üsküdar Üniversitesi olurken Kurucu Rektör Prof. Dr. Nevzat Tarhan ve beraberindeki araştırmacılardan Üsküdar Üniversitesi Öğretim Üyesi Doç. Dr. Türker Tekin Ergüzel yürüttükleri çalışmalara ilişkin zirve kapsamında sunum gerçekleştirdi. Bilim liderlerinin gündeminde kanser, nöroteknoloji var… Prof. Dr. Nevzat Tarhan başkanlığında ME+ Brain Initiative, Societyfor Brain Mapping and Therapeutics (SBMT) adına Dr. Babak Kateb, Hindistan Brain Initiative adına Sandip Chatterjee, Asia – Pasific adına Dr. Asra Al Fauzi ve Sunder Vakfı Başkanı Keerthy Sunder zirve kapsamında N20’de açılış konuşmaları gerçekleştirdi. Bilim insanlarının gündeminde ise; Kanser Tedavisi, İntihar Önleme, Nöroteknoloji, Bağımlılık Önleme ve Giyilebilir Teknolojiler başlıkları vardı.  Türkiye’de yürütülen çalışmalar dikkat çekti… Dünya basınında da geniş yer bulan zirve kapsamında “Theta Burst and Neuromodulation Applications” başlıklı sunumuyla oturum başkanı Prof. Nevzat Tarhan ve “AI Based Neuroscience Applications and NP Model” sunumuyla Doç. Dr. Türker Tekin Ergüzel çalışmalarını paylaştı. Nöroteknoloji odaklı çalışmaları uluslararası araştırmacıların ilgisini çekerken Prof. Nevzat Tarhan sunumunda nöromodülasyon tekniklerini, rTMS’in elektriksel aktiviteyi nasıl etkilediğine dikkat çekti. Tarhan, depresyon, OKB tedavisinde ve komorbid psikiyatrik hastalıklarda kullanımını, yan etkilerini ele aldı. NP Beyin Hastanesinin bağımlılık, rTMS theta burst protokollerini ve nöronavigasyon destekli tedavi uygulamalarını 9 farklı ülkeden araştırmacılar ve eş zamanlı olarak Society for Brain Mapping and Therapeutics (SBMT) Youtube kanalı üzerinden olarak izleyicileri ile paylaştı. Yapay Zeka destekli hastalık sınıflandırma modeli… Öte yandan Doç. Dr. Türker Ergüzel de NP Beyin Hastanesi için tasarlanan ve Prof. Nevzat Tarhan tarafından patent başvurusu yapılan Yapay Zeka destekli hastalık sınıflandırma modelinin ilk versiyonu “NP Model” sunumunu gerçekleştirdi. Özellikle artan veri çözünürlüğü ve boyutu ile birlikte yetersiz kalan geleneksel sınıflandırma algoritmaları yerine kullanılan LSTM, CNN mimarileri ile tasarlanan hastalık sınıflandırma modeli OKB – Sağlıklı Kontrol grubu için ve Bipolar – Sağlıklı Kontrol grupları için external validation işlemleri ile simüle edilerek araştırmacılar ile paylaşıldı. Tarhan: “Çalışmalarımızla ülkemizde referans adres olmak bizi mutlu ediyor” Üsküdar Üniversitesi ve NP Beyin Hastanesinin Nöroteknoloji odaklı çalışmalarının uluslararası araştırmacılar tarafından yakın ilgi görmesinin kendilerini çok mutlu ettiğini, ülkemizin bu alanlardaki çalışmalarının referans adres olmaktan ise mutluluk duyduklarını belirten Tarhan’a bir de ödül takdim edildi. Yazar Prof. Dr. Nevzat Tarhan’a Bestseller ödülü verildi “Rumi Terapi” ve “İnanç Psikolojisi” kitapları Endonezya’da “Bestseller” listesine giren Tarhan’a “Bestseller” ödülü takdim edildi. Tarhan’a ödülünü G20 / N20 zirvesinde “Indonesian Neurosurgical Society” başkanı Joni Wahyuhadi tarafından verildi. Okurları tarafından “Bilim ve inancı birlikte harmanlanmasına dair etkileyici bir kitap” olarak değerlendirilen Tarhan’ın kitapları N20 delegasyon üyelerine Prof. Dr. Nevzat Tarhan’ın imzası ile paylaşıldı. * Zirveye ilişkin bilgilendirme sunumuna ulaşmak için tıklayınız. Üsküdar Haber Ajansı (ÜHA)

Chopra Foundation Movement Recognized by Leading Brain Mapping Society and Foundation at the “Gathering For The Cure” Gala

LOS ANGELES, March 9, 2022 /PRNewswire/ — The Chopra Foundation is pleased to announce it will be the recipient of the 2022 Beacon of Courage and Dedication Award from the Society for Brain Mapping and Therapeutics (SBMT) and International Brain Mapping Foundation (IBMF). This award is presented to the organizations and individuals who have raised awareness about neurological and neuropsychiatric disorders and impacted the science, technology and innovation for related patient care. On Friday, March 11, 2022, IBMF and SBMT will jointly hold the 19th annual “Gathering for the Cure Gala“ in Los Angeles, where Dr. Deepak Chopra, the pioneer in wellness and integrative medicine, will accept the award. Recognizing the Foundation’s vision and traction with its Never Alone movement, the award citation reads: The Society for Brain Mapping and Therapeutics recognizes your role in increasing awareness about Mental Health and Suicide Prevention through your “Never Alone Initiative”. We recognize and laud your efforts for highlighting the challenges faced by the COVID19 pandemic, wars across the globe, which impacts patients with neurological and neuropsychiatric disorders and their families. You continue to lead by example and continue to advocate for public support for brain research, aid for caregivers and care takers.  Co-founded by Gabriella Wright, actor and international humanitarian, the Foundation’s NeverAlone initiative and related programs will inspire “Global healing through love in action and sharing the experience in joy so that We are Never Alone,” according to Dr. Chopra. Having recently turned 75, Dr. Chopra joyfully shares, “I have entered my final season, my winter.”  As such, with a renewed focus on service, Dr. Chopra has engaged a new team to lead the future of the Chopra Foundation including CEO Poonacha Machaiah, COO Justin Nahama, and renowned philanthropic expert Caren Croland Yanis, former Executive Director of the Oprah Winfrey foundations.  Foundation COO Justin Nahama, a Marine veteran and autism parent, says “Veterans and families with impacted children are incredibly lucky for the important trails blazed by SBMT and IBMF—under the vision and leadership of Dr. Kateb—to support caregivers during a lifetime of service.” Nahama continues, “The Chopra Foundation is proud to partner with SBMT and IBMF to expand its NeverAlone movement globally and advance the diagnostics and therapeutics for patients with neurological and neuropsychiatric challenges.” The Gala will unite scientists, technologists, policymakers, and inspiring individuals who have impacted the field of neuroscience globally. Over 450 industry-leading scientists, celebrities, healthcare executives, surgeons and engineers will be celebrating multiple award presentations to their colleagues. The Joint Chief of Staff of the US Armed Forces, General Mark Milley, will be also receiving an award for the heroic effort to serve and protect millions of Americans during the COVID19 pandemic. Over the past 20 years, the SBMT and IBMF have been on the forefront of neuroscience policy, scientific discoveries and technological development in the field of clinical and translational neuroscience. The foundation has been bringing state-of-the-art science and technology to wounded soldiers, veterans, and civilians. Both SBMT and IBMF have been instrumental in both the design and formulation of former President Obama’s BRAIN initiative, G20 Summit Brain Initiative/ Neuroscience 20 (Brain, Spine and Mental Health) and California’s Brain Technology and Innovation Park Initiative. For more information on the Gala and its program schedule: https://www.worldbrainmapping.org/Annual-Awards-Gala/ https://www.worldbrainmapping.org/Annual-Congress/Scientific-Program-Schedule To learn more about the Chopra Foundation: https://choprafoundation.org/ To learn more about SBMT: www.WorldBrainMapping.org To learn more about IBMF: www.BrainMappingFoundation.Org Contact:Kristen Marion623-308-2638 331559@email4pr.com SOURCE The Chopra Foundation

17th Annual World Congress of Society for Brain Mapping & Therapeutics

Date & LocationThursday, July 8, 2021, 7:00 AM – Sunday, July 11, 2021, 5:00 PM Target Audience Specialties – Academic/Research, Neurology, Neurosurgery, Nuclear Radiology, Oncology OverviewThe 17th Annual World Congress of SBMT will bring together physicians, scientists, policy makers, funding agencies, and industry to further the advances and applications in brain and spinal cord mapping and image-guided therapies (operative and non-operative). This conference will create a critical mass by introducing synergy among inter-disciplinary researchers and clinicians to further analyze brain function and the nervous system. For additional information: https://www.worldbrainmapping.org/Annual-Congress Objectives AccreditationACCREDITATION STATEMENTThe Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CREDIT DESIGNATION STATEMENTThe Johns Hopkins University School of Medicine designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity. Richard D. Abbey, PhDClinic DirectorAbbey Neuropsychology Clinic Orange Alem, PhDFounder/ScientistFieldLine Inc. Gabriel Altman, DCCo-ownerKinetix365 Michael Beyeler, PhDAssistant ProfessorUniversity of California, Santa Barbara Delia Cabrera DeBuc, PhDUniversity of Miami Gert Cauwenberghs, PhDProfessorUC San Diego Osman Cerezci, PhDProfUskudar UniversityIstanbul, Turkey Iype Cherian, MDDirector, Counselor General Member, Associate Chief Editor, ReviewerCleveland Clinic Yu Mike Chi, PhDCognionics, Inc. Gregory Clark, PhDAssoc. Prof.Univ. of Utah Justin Dye, MDAssistant ProfessorLoma Linda University Turker Tekin Erguzel, PhDUskudar UniversityIstanbul, Turkey Zhaoyang Fan, PhDAssociate ProfessorUniversity of Southern California Jeffrey Farkas, MDNYU Michael G Fehlings, MD, PhDProfessor of Neurosurgery/Vice Chair ResearchUniversity of Toronto ,Toronto, Canada DeAnn Fitzgerald, ODODDr. Fitzgerald & Associates Michael Flomenhaft, J.D.Flomenhaft Law Firm Brain Justice Dale Foster, PhDPresidentNeuroSource LLC Jenny Garbus, COT, CBISNeuro Vision Rehabilitation Institute Hugo Geerts, PhDCertara Robert Hariri, MD, PhDChairman FounderCelularity Heather HeitkotterGraduate StudentMedical College of Wisconsin Ryan M. Hill, PhDUniversity of NottinghamNottingham, United Kingdom Elliot Hogg, MDAssistant ProfessorCedars-Sinai Medical Center Keyne Johnson, MDOwner/CEOBrain and Spine Institute for Children Babak Kateb, MDChairman and CEOSociety for Brain Mapping and Therapeutics (SBMT) Spencer Kellis, PhDCalifornia Institute of Technology Jacob Koffler, PhDUCSD James Kozloski, PhDResearch Staff MemberIBM Research Christopher Lee, PhDUniversity of California San Diego Vivien Lee, MDNeurologistOhio State University Medical Center Kai-Uwe Lewandrowski, MDSurgeonCenter For Advanced Spine Care of Southern Arizona Mark Liker, MDAssistant ProfessorUniversity of Southern California Joel Lubar, PhDPRESIDENTSOUTH EASTERN NEUROFEEDBACK INST Codrin Lungu, MDNINDS, NIH Nancy J Major, MAVision TherapistCentral Coast Vision and Learning Shannon Mandel, PA-CMind Eye Institute Zoltan Mari, MDAssociate ProfessorJohns Hopkins University Eric Marvin, DOVirginia Tech Carilion Clinic Brian Mehling, MDOrthopedic Surgeon CMO, Blue Horizon InternationalBlue Horizon International Roger Miller, PhDProgram DirectorNational Institutes of Health Kelly Mills, MD Hiroyuki Mino, PhDProfessorKanto Gakuin UniversityYokohama, Japan Virendra Mishra, PhDAssociate StaffCleveland Clinic Lou Ruvo Center for Brain Health Martin M Mortazavi, MD, NeurosurgeonChairmanCalifornia Institute of Neuroscience Rebeca Perez-Alfayate, MD, PhD, NeurosurgeonNeurosurgeonHospital Clinico San CarlosMadrid , Spain Amy Pruszenski, ODDr.Visual Victory Training, PLLC Afsaneh Rabiei, PhDProfessor Mechanical and Aerospace EngineeringNorth Carolina State University Albert Recio, MDPhysicianKennedy Krieger Institute/ JHH Liana Rosenthal, MDAssistant ProfessorJohns Hopkins School of Medicine Terence Sanger, MDUCI Fabien Scalzo, PhDAssociate ProfessorPepperdine & UCLA Selim Seker, PhDUskudar Universityistanbul, Turkey Vishal Shah, PhDCEO and FounderQuSpin, Inc. Lingyan Shi, PhDAssistant ProfessorUniversity of San Diego Tony Spahr, PhDSr. Dir. Research & TechnologyAdvanced Bionics Noelle Stiles, PhDUSC Viktor Szeder, MD, PhDAssociate Clinical Professor of Radiology and NeurosurgeryUCLA Fabian Tai, OD Ambooj Tiwari, MDClinical Assistant ProfessorNYU School of Medicine Derek Tong, ODClinic DirectorCenter for Vision Development Optometry Inc. Gabor Toth, MDAssociate ProfessorCleveland Clinic Christopher Tyler, PhDSenior ScientistSmith-Kettlewell Eye Research Institute Suraj Upadhyaya, PhDMidwestern University Pablo Villablanca, MDUCLA Ryan R Walsh, MD, PhD, FAANAssociate ProfessorMuhammad Ali Parkinson Center at Barrow Neurological Institute Yiwen Wang, PhDAssistant ProfessorHong Kong University of Science and TechnologyKowloon, Hong Kong Danny JJ Wang, PhDProfessor of Neurology and Radiology; Director of Imaging Technology InnovationUniversity of Southern California Eric J Wang, MDAssistant ProfessorJohns Hopkins Medicine Robert Watkins IV, MDCo-DirectorMarina Spine Center Yuxiao Yang, PhDPostdocUniversity of Southern California Anthony T Yeung, MD, Clinical Professor of NeurosurgeryExecute DirectorInternational Intradiscal Therpy Society Gene J Yu, PhDUniversity of Southern California Theodoros Zanos, PhDAssistant ProfessorFeinstein Institutes for Medical Research Hekmat Zarzour, MD, Assistant ProfessorAssistant ProfessorJefferson University Yongxin Zhao, PhDAssistant ProfessorCarnegie Mellon University Zion Zibly, MD

Brain Mapping Foundation to award Montel Williams, Sahel Rose, Ken Fisher, Anthony Fauci, Robert Hariri, Sanjay Gupta, Saleem Abdulrauf, Ro Khanna, Eva Hsieh, Harrison Ford, Michael E. Phelps and many more luminaries at its 18th Annual Gathering for Cure Gala

LOS ANGELES, July 7, 2021 /PRNewswire/ — Brain Mapping Foundation (BMF) was established in 2003 to help fast-tracking diagnostics and therapeutics for wounded soldiers, veterans, and civilians with neurological, spine, and neuro-psychiatric disorders. Since then, the organization has been pioneering lifesaving therapeutics and introducing trailblazing initiatives such as Neuroscience20 (Brain20, Spine20, Mental20) and Brain Technology and Innovation Park (BTIP) while celebrating pioneers in the fields. “BMF award banquet is like the Oscars for neuroscience. Annually, we identify pioneers in neuroscience, neurotech, policy, humanitarian, advocacy, and student recognitions” said, Dr. Babak Kateb, President of Brain Mapping Foundation. “We are honored to celebrate such remarkable individuals who have a passion for humanity and helping other. I am also honored to co-hots the gala with my remarkable co-host actress Gabriella Wright“. The 18th Annual Gathering for the Cure of the BMF will include a red-carpet interview with pioneering scientists, engineers, physicians, surgeons, policymakers, and technologists as well as celebrities who are raising awareness about neurological, spine and mental health. A worldly renowned musician Michael Fitzpatrick  to perform at the event, with auctions and many other exciting entertainments will be included.  To book your ticket please visit: https://www.worldbrainmapping.org/Annual-Awards-Gala/ About BMF: www.BrainMappingFoundation.Org Contacts: Keri Ann Kimball keriann@kimballentertainment.com  C: 310-721-4912   O: 650-922-6259  SOURCE Society for Brain Mapping and Therapeutics

AIM MEDICAL ROBOTICS TO PRESENT AND EXHIBIT AT 18TH ANNUAL WORLD CONGRESS OF SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS (SBMT)

Presentation by Dr. Julie Pilitsis, Chief Medical Advisor & Co-Founder, to take place on July 10th at 1:45 pm PSTPresentation by Dr. Greg Fischer, Chief Scientific Advisor & Co-Founder, to take place on July 11th at 4:45 pm PST FORT LAUDERDALE, Fla., July 7, 2021 /PRNewswire/ — AiM Medical Robotics, a leading developer of MRI-safe intraoperative robotics for neurosurgery, today announced that they will be presenting and exhibiting at the prestigious 18th Annual World Congress of Society for Brain Mapping and Therapeutics (SBMT), which will be held in Los Angeles on July 8th – 11th. The program will be featuring state-of-the-art science and technology in the field of neuroscience and neurosurgery, and it will have close to 900 presenters and 10 keynotes. The co-founders and inventors of AiM Medical Robotics, Dr. Greg Fischer of the Worcester Polytechnic Institute and Dr. Julie Pilitsis of the Albany Medical Center, will be presenting the latest updates on their NIH-funded research for brain tumor ablation during the SBMT scientific sessions. Additionally, Bob Cathcart, President & CEO of AiM Medical Robotics, and Dr. Jonathan Sackier, Director, will be meeting with clinicians and industry leaders during the Company’s exhibition at the Congress.  “SBMT brings pioneers of neurosurgery and trailblazing companies together with game changing policy makers  in order to rapidly fast track diagnostics, devices and therapeutics for patients with neurological, spine and neuro-psychiatric disorders; AiM Medical Robotics is one of the leaders in the emerging field of artificial intelligence-guided therapy” said, Dr. Babak Kateb, founding chairman of the board of directors & CEO of SBMT, President and Scientific Director of the Brain Mapping Foundation, Director of National Center for Nano-Bio-Electronics, and Director of Brain Technology and Innovation Park. Bob Cathcart commented, “We are extremely excited to have been asked to participate in this outstanding gathering of world leaders in Neurology. SBMT is at the forefront of discovery for the diagnosis and treatment of brain disorders. We are honored to have Dr. Fischer and Dr. Pilitsis participate in the scientific sessions to share their enthusiasm and the accomplishments that we have seen with our paradigm-shifting technology. Our MRI-compatible robotic system will give surgeons the ability to utilize MRI guidance for complex neurosurgical procedures. By combining the Real Time feedback of the MRI and the precision and accuracy of the robot, surgeons can confidently reach targets deep in the brain the first time every time.” About AiM Medical Robotics AiM Medical Robotics is a privately held biotechnology company currently focused on the development of MRI-compatible advanced robotics that are precision-focused and portable. You can follow AiM at www.aimmedrobotics.com and on LinkedIn at https://www.linkedin.com/company/aim-medical-robotics.    Forward Looking Statements This release may contain forward-looking statements that are subject to risks and uncertainties. Such forward-looking statements may include but are not necessarily limited to statements that relate to the advancement and development of the company’s robot or technologies, when used herein, words such as “anticipate”, “being”, “will”, “plan”, “may”, “continue”, and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking. All forward-looking statements are based upon AiM Medical Robotics’ current expectations and various assumptions. AiM Medical Robotics believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. AiM Medical Robotics may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important factors.  Readers should not place undue reliance on the forward-looking statements, which reflect management’s view only as of the date hereof.  AiM Medical Robotics undertakes no obligation to publicly revise these forward-looking statements to reflect subsequent events or circumstances. Contacts:Bob CathcartChief Executive OfficerAiM Medical Robotics, Inc.(862) 703-0253bcathcart@aimmedrobotics.com  Investors:Doug NissinoffCorporate CommunicationsAiM Medical Robotics, Inc.(954) 204-6745IR@aimmedrobotics.com 

Doctors Around The World Offer to Help Ukraine

A network of more than 100,000 doctors from around the world are pulling together to help the people of Ukraine. Lauren Coronado reports for the NBC4 News at 11 p.m. on March 11, 2022.